comparemela.com

Page 2 - Hangzhou Zhongmei Huadong Pharmaceutical Co Ltd News Today : Breaking News, Live Updates & Top Stories | Vimarsana

$25m Q1 loss reported for Kiniksa

$25m Q1 loss reported for Kiniksa
royalgazette.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from royalgazette.com Daily Mail and Mail on Sunday newspapers.

China Anastrozole Market Report 2021: Sales 2016-2020, Major Manufacturers, Prices 2020-2021, Prospects 2021-2025

Greenberg Traurig Represents Huadong Medicine in Two Licensing Deals Totalling Over $1 6 Billion in Value | News

Wayne H. Elowe, co-chair of the Life Sciences and Medical Technology Group at global law firm Greenberg Traurig, LLP and co-chair of the firm’s Atlanta Corporate Practice, led the Greenberg Traurig team representing Huadong Medicine Co., Ltd., one of the leading pharmaceutical companies in China with a focus on oncology and Antibody-drug Conjugates research, development, and commercialization, on two large licensing deals, both of which closed in February 2022. These deals mark the continuation of a longstanding relationship between Huadong Medicine and Greenberg Traurig Shareholders Elowe and Dawn (Dan) Zhang (Shanghai) who have represented Huadong in numerous transactions.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.